SAN JOSE, Calif., May 22, 2023 /PRNewswire/ — Anixa Biosciences, Inc. ANIX, a biotechnology company focused on the treatment and prevention of cancer, today announced that, in conjunction with its partner Moffitt Cancer Center, it has commenced treatment of the second patient in the ongoing clinical trial of its novel…Read More
Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CART Clinical Trial Anixa Biosciences NASDAQANIX
